Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis

REFERENCES

• Meqi SA, Deshpande SG. Ocular drug delivery. In: Jain NK, eds. Controlled and Novel Drug Delivery. New Delhi: CBS Publishers; 2002:82–84.
   Google Scholar
• Sasaki H, Yamamura K, Nishida K, et al. Delivery of drugs to the eye by topical application. Prog Retin Eye Res. 1996;15:583–620.
   Web of Science ®Google Scholar
• Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39–43.
   Web of Science ®Google Scholar
• Jtirvinen K, Vinen TJ, Arto US. Ocular absorption following topical delivery. Adv Drug Deliver Rev. 1995;16:3–19.
   Web of Science ®Google Scholar
• Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58:1131–1135.
   PubMed Web of Science ®Google Scholar
• Swarbrick J, Boylan J. Ocular drug formulation and delivery. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker; 1995:43–75.
   Google Scholar
• Ranade VV, Hollinger MA. Intranasal and ocular drug delivery. In: Drug Delivery Systems. Boca Raton: CRC press; 1996:209–238.
   Google Scholar
• Felt O, Baeyens V. Mucosal drug delivery: ocular. Encyclopedia of Controlled Drug Delivery. Vol. 2. New York: John Wiley and Sons; 1999:605–626.
   Google Scholar
• Chiou GCY, Watanabe K. Drug delivery to the eyes. Methods of drug delivery. In: Ihler GM, ed. International Encyclopedia of Pharmacology and Therapeutics. Oxford: Pergamon Press; 1986:203–210.
   Google Scholar
• Kesavan K, Nath G, Pandit JK. Sodium alginate based mucoadhesive system for gatifloxacin and its in vitro antibacterial activity. Sci Pharm. 2010;78:941–957.
   PubMedGoogle Scholar
• Kesavan K, Kant S, Singh PN, et al. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel. Curr Eye Res. 2011;36:918–929.
   PubMed Web of Science ®Google Scholar
• Kesavan K, Balasubramaniam J, Kant S, et al. Newer approaches for optimal bioavailability of ocularly delivered drugs: review. Curr Drug Deliv. 2011;8:172–193.
   PubMed Web of Science ®Google Scholar
• Dalhoff A. Pharmacodynamics of fluoroquinolones. J Antimicrob Chemother. 1999;43:51–59.
   PubMed Web of Science ®Google Scholar
• Schoenwald RD. The importance of optimizing cornea! penetration. In: Saettone MF, Bucci M, Speiser P, eds. Ophthalmic Drug Delivery. Biopharmaceutical, Technological and Clinical Aspects. Padova: Livinia Press; 1987:151–160.
   Google Scholar
• Ahmed I, Patton TF. Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption. Int J Pharm. 1987;38:9–21.
   Web of Science ®Google Scholar
• Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst. 1999;16:461–521.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliver Rev. 2000;45:89–121.
   PubMed Web of Science ®Google Scholar
• Alany RG, Rades T, Nicoll J, et al. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. J Control Rel. 2006; 111, 145–152.
   Google Scholar
• Silva-Cunha A, Fialho SL, Carneiro LB, et al. Microemulsões como veículos de drogas para administração ocular tópica. Arq Bras Oftalmol. 2003;66:385–391.
   Google Scholar
• Kesavan K, Pandit JK, Kant S, et al. Positively charged microemulsions of dexamethasone: comparative effects of two co-surfactants on ocular drug delivery and bioavailability. Ther Deliv. 2013;4:1385–1395.
   PubMedGoogle Scholar
• Kesavan K, Kant S, Pandit JK. Therapeutic effectiveness in the treatment of experimental bacterial keratitis with ion-activated mucoadhesive hydrogel. Ocul Immunol Inflamm. 2015; Aug 19:1–4.
   Web of Science ®Google Scholar
• Kesavan K, Kant S, Singh PN, et al. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation. Curr Eye Res. 2013;38:342–352.
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker EM, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
   Web of Science ®Google Scholar
• Kesavan K, Nath G, Pandit JK. Preparation and in vitro antibacterial evaluation of gatifloxacin mucoadhesive gellan system. Daru. 2010;18:237–246.
   PubMed Web of Science ®Google Scholar
• Draize JH, Woodard G, Calvey HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;81:377–390.
   Google Scholar
• Charoo NA, Kohli K, Ali A. Preparation of in situ forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: In vitro and in vivo studies. J Pharm Sci. 2003;92:407–413.
   PubMed Web of Science ®Google Scholar
• Vandamme TF. Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog Retin Eye Res. 2002;21:15–34.
   PubMed Web of Science ®Google Scholar
• Alany RG, Tucker IG, Davies NM, et al. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm. 2001;27:31–38.
   PubMed Web of Science ®Google Scholar
• Aboofazeli R, Lawrence MJ. Investigations into the formation and characterization of phospholipid microemulsions. I. Pseudoternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristate. Int J Pharm. 1993;93:161–175.
   Web of Science ®Google Scholar
• Sterzel W, Bartnik FG, Matthies W, et al. Comparison of two in vitro and two in vivo methods for the measurement of irritancy. Toxicol In Vitro. 1990;4:698–701.
   PubMed Web of Science ®Google Scholar
• Leung R, Shah DO. Solubilization and phase equilibria of water-in-oil microemulsions: I. Effects of spontaneous curvature and elasticity of interfacial films. J Coll Interface Sci. 1987;120:320–329.
   Web of Science ®Google Scholar
• Baker RC, Florence AT, Tadros TF, et al. Investigations into the formation and characterization of microemulsions. I. Phase diagrams of the ternary system water–sodium alkyl benzene sulfonate–hexanol and the quaternary system water–xylene–sodium alkyl benzene sulfonate–hexanol. J Coll Interface Sci. 1984;100:311–331.
   Web of Science ®Google Scholar
• Charman SA, Charman WN, Rogg MC, et al. Selfemulsifying systems formulation and biological evaluation of an investigative lipophilic compound. Pharm Res. 1992;9:87–94.
   PubMed Web of Science ®Google Scholar
• Fialho SL, Da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Exp Ophthalmol. 2004;32:626–632.
   PubMed Web of Science ®Google Scholar
• Mathis GA. Clinical ophthalmic pharmacology: therapeutics: ocular drug delivery. In: Gelatt KN, ed. Veterinary Ophthalmology. Orlando: Lippincott, Williams & Wilkins; 1999:291–297.
   Google Scholar
• Ooteghem VMM. Formulations of ophthalmic solutions and suspensions. Problems and advantages. In: Edman P, ed. Biopharmaceutics of Ocular Drug Delivery. Boca Raton: CRC Press; 1993:31–32.
   Google Scholar
• Zhu H, Chauhan A. effect of viscosity on tear drainage and ocular residence time. Optom Vis Sci. 2008;E715-E725.
   Google Scholar
• Snibson GR, et al. Ocular surface residence times of artificial tear solutions. Cornea. 1992;11(4):288–293.
   PubMed Web of Science ®Google Scholar
• Lee PJ, Langer R, Shastri VP. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res. 2003;20:264–269.
   PubMed Web of Science ®Google Scholar